과제정보
본 연구는 부산대학교 기본연구지원사업(2년)의 지원을 받아 수행되었음.
참고문헌
- International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. Available from: https://gco.iarc.fr/today/fact-sheets-cancers [Accessed 28th September 2022].
- Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? Cancer. 2015;121(5):664-72. https://doi.org/10.1002/cncr.29098
- Herzog BH, Devarakonda S, Govindan R. Overcoming Chemotherapy Resistance in SCLC. J Thorac Oncol. 2021;16(12):2002-15. https://doi.org/10.1016/j.jtho.2021.07.018
- Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):1-20. https://doi.org/10.1038/s41572-020-00234-1
- Minami T, Kijima T, Kohmo S, Arase H, Otani Y, Nagatomo I, et al. Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis. Sci Rep. 2013;3:2669:1-11.
- Quaresma M, Coleman MP, Rachet B. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study. Lancet. 2015;385(9974):1206-18. https://doi.org/10.1016/S0140-6736(14)61396-9
- Karachaliou N, Pilotto S, Lazzari C, Bria E, de Marinis F, Rosell R. Cellular and molecular biology of small cell lung cancer: an overview. Transl Lung Cancer Res. 2016;5(1):2-15.
- Cancer.Net Editorial Board. Lung cancer - small cell - statistics. Available from: https://www.cancer.net/cancer-types/lung-cancer-small-cell/statistics [Accessed 28th September 2022].
- Pezzani R, Salehi B, Vitalini S, Iriti M, Zuniga FA, Sharifi-Rad J, et al. Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective. Medicina (Kaunas). 2019;55(4):1-16.
- Castaneda AM, Melendez CM, Uribe D, Pedroza-Diaz J. Synergistic effects of natural compounds and conventional chemotherapeutic agents: recent insights for the development of cancer treatment strategies. Heliyon. 2022;8(6):e09519.
- Liu Z, Ma L, Zhou GB. The main anticancer bullets of the Chinese medicinal herb, thunder god vine. Molecules. 2011;16(6):5283-97. https://doi.org/10.3390/molecules16065283
- Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, et al. Anti-cancer natural products isolated from chinese medicinal herbs. Chin Med. 2011;6(1):27:1-15. https://doi.org/10.1186/1749-8546-6-1
- Stasiak N, Kukula-Koch W, Glowniak K. Modern industrial and pharmacological applications of indigo dye and its derivatives-a review. Acta Pol Pharm. 2014;71(2):215-21.
- State Pharmacopoeia Commission of the PRC. Pharmacopoeia of the People's Republic of China. China: People's Medical Publishing House; 2005.
- Tang W., Eisenbrand G. Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine. Berlin: Springer-Verlag; 1992.
- Han J. Traditional Chinese medicine and the search for new antineoplastic drugs. J Ethnopharmacol. 1988;24(1):1-17. https://doi.org/10.1016/0378-8741(88)90135-3
- Yang MH, Wan WQ, Luo JS, Zheng MC, Huang K, Yang LH, et al. Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical study. Am J Hematol. 2018;93(12):1467-73. https://doi.org/10.1002/ajh.25271
- Liau BC, Jong TT, Lee MR, Chen SS. LC-APCI-MS method for detection and analysis of tryptanthrin, indigo, and indirubin in daqingye and banlangen. J Pharm Biomed Anal. 2007;43(1):346-51. https://doi.org/10.1016/j.jpba.2006.06.029
- Cao Z, Yang F, Wang J, Gu Z, Lin S, Wang P, et al. Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer. J Med Chem. 2021;64(20):15280-96. https://doi.org/10.1021/acs.jmedchem.1c01311
- Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, et al. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci U S A. 2005;102(17):5998-6003. https://doi.org/10.1073/pnas.0409467102
- Wang H, Wang Z, Wei C, Wang J, Xu Y, Bai G, et al. Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship. Eur J Med Chem. 2021;223:113652:1-30.
- Hsieh WL, Lin YK, Tsai CN, Wang TM, Chen TY, Pang JH. Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes. J Dermatol Sci. 2012;67(2):140-6. https://doi.org/10.1016/j.jdermsci.2012.05.008
- Gao W, Guo Y, Wang C, Lin Y, Yu L, Sheng T, et al. Indirubin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice through the inhibition of inflammation and the induction of Foxp3-expressing regulatory T cells. Acta Histochem. 2016;118(6):606-14. https://doi.org/10.1016/j.acthis.2016.06.004
- Lin YK, Chang SH, Yang CY, See LC, Lee BH, Shih IH. Efficacy and safety of indigo naturalis ointment in Treating Atopic Dermatitis: A randomized clinical trial. J Ethnopharmacol. 2020;250:112477:1-8.
- Kaur R, Manjal SK, Rawal RK, Kumar K. Recent synthetic and medicinal perspectives of tryptanthrin. Bioorg Med Chem. 2017;25(17):4533-52. https://doi.org/10.1016/j.bmc.2017.07.003
- Chiang YR, Li A, Leu YL, Fang JY, Lin YK. An in vitro study of the antimicrobial effects of indigo naturalis prepared from Strobilanthes formosanus Moore. Molecules. 2013;18(11):14381-96. https://doi.org/10.3390/molecules181114381
- Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13:1-6. https://doi.org/10.1186/1758-2946-6-1
- Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717:1-13.
- Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523:1-10. https://doi.org/10.1038/s41467-018-07882-8
- Liu SG, Luo GP, Qu YB, Chen YF. Indirubin inhibits Wnt/beta-catenin signal pathway via promoter demethylation of WIF-1. BMC Complement Med Ther. 2020;20(1):250:1-10. https://doi.org/10.1186/s12906-019-2780-5
- Hoessel R, Leclerc S, Endicott JA, Nobel ME, Lawrie A, Tunnah P, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol. 1999;1(1):60-7. https://doi.org/10.1038/9035
- Premanathan M, Radhakrishnan S, Kulangiappar K, Singaravelu G, Thirumalaiarasu V, Sivakumar T, et al. Antioxidant & anticancer activities of isatin (1H-indole-2,3-dione), isolated from the flowers of Couroupita guianensis Aubl. Indian J Med Res. 2012;136(5):822-6.
- Chen DL, Zhou D, Chu W, Herrbrich P, Engle JT, Griffin E, et al. Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody. Nucl Med Biol. 2012;39(1):137-44. https://doi.org/10.1016/j.nucmedbio.2011.08.001
- Ferraz de Paiva RE, Vieira EG, Rodrigues da Silva D, Wegermann CA, Costa Ferreira AM. Anticancer Compounds Based on Isatin-Derivatives: Strategies to Ameliorate Selectivity and Efficiency. Front Mol Biosci. 2020;7:627272:1-24. https://doi.org/10.3389/fmolb.2020.00001
- Jahng Y. Progress in the studies on tryptanthrin, an alkaloid of history. Arch Pharm Res. 2013;36(5):517-35. https://doi.org/10.1007/s12272-013-0091-9
- Yuan M, Zhao Y, Arkenau HT, Lao T, Chu L, Xu Q. Signal pathways and precision therapy of small-cell lung cancer. Signal Transduct Target Ther. 2022;7(1):187:1-18. https://doi.org/10.1038/s41392-021-00710-4
- Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226(4678):1097-9. https://doi.org/10.1126/science.6093263
- Wang C, Zhang J, Yin J, Gan Y, Xu S, Gu Y, et al. Alternative approaches to target Myc for cancer treatment. Signal Transduct Target Ther. 2021;6(1):117:1-14. https://doi.org/10.1038/s41392-020-00451-w
- Baugh EH, Ke H, Levine AJ, Bonneau RA, Chan CS. Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ. 2018;25(1):154-60. https://doi.org/10.1038/cdd.2017.180
- George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524(7563):47-53. https://doi.org/10.1038/nature14664
- el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75(4):817-25. https://doi.org/10.1016/0092-8674(93)90500-p
- Karimian A, Ahmadi Y, Yousefi B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 2016;42:63-71. https://doi.org/10.1016/j.dnarep.2016.04.008
- Peng H, Yuan X, Shi R, Wei X, Ren S, Yan C, et al. PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species. Eur J Pharmacol. 2013;718(1-3):459-68. https://doi.org/10.1016/j.ejphar.2013.07.038